{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T04:58:38Z","timestamp":1793336318949,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T00:00:00Z","timestamp":1576454400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T00:00:00Z","timestamp":1576454400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s00261-019-02366-9","type":"journal-article","created":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T09:04:07Z","timestamp":1576487047000},"page":"354-364","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Primary sclerosing cholangitis: diagnostic performance of MRI compared to blood tests and clinical scoring systems for the evaluation of histopathological severity of disease"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4713-6453","authenticated-orcid":false,"given":"Christopher","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amita","family":"Kamath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Hectors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Putra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Kihira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Octavia","family":"Bane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jawad","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Babb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swan","family":"Thung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bachir","family":"Taouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,16]]},"reference":[{"issue":"8","key":"2366_CR1","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1155\/2008\/824168","volume":"22","author":"MG Silveira","year":"2008","unstructured":"Silveira, M.G. and K.D. Lindor, Primary sclerosing cholangitis. Can J Gastroenterol, 2008. 22(8): p. 689-98.","journal-title":"Can J Gastroenterol"},{"issue":"1","key":"2366_CR2","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s00261-016-0847-z","volume":"42","author":"JM Ni Mhuircheartaigh","year":"2017","unstructured":"Ni Mhuircheartaigh, J.M., et al., Early Peribiliary Hyperenhancement on MRI in Patients with Primary Sclerosing Cholangitis: Significance and Association with the Mayo Risk Score. Abdom Radiol (NY), 2017. 42(1): p. 152-158.","journal-title":"Abdom Radiol (NY)"},{"issue":"4","key":"2366_CR3","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1002\/jmri.24250","volume":"39","author":"H Nilsson","year":"2014","unstructured":"Nilsson, H., et al., Dynamic gadoxetate-enhanced MRI for the assessment of total and segmental liver function and volume in primary sclerosing cholangitis. J Magn Reson Imaging, 2014. 39(4): p. 879-86.","journal-title":"J Magn Reson Imaging"},{"issue":"5","key":"2366_CR4","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.crad.2013.12.008","volume":"69","author":"R Nolz","year":"2014","unstructured":"Nolz, R., et al., Diagnostic workup of primary sclerosing cholangitis: the benefit of adding gadoxetic acid-enhanced T1-weighted magnetic resonance cholangiography to conventional T2-weighted magnetic resonance cholangiography. Clin Radiol, 2014. 69(5): p. 499-508.","journal-title":"Clin Radiol"},{"issue":"5","key":"2366_CR5","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1053\/j.gastro.2005.08.017","volume":"129","author":"R Olsson","year":"2005","unstructured":"Olsson, R., et al., High-dose ursodeoxycholic acid in primary sclerosing cholangitis: a 5-year multicenter, randomized, controlled study. Gastroenterology, 2005. 129(5): p. 1464-72.","journal-title":"Gastroenterology"},{"issue":"4","key":"2366_CR6","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1002\/hep.28256","volume":"63","author":"CY Ponsioen","year":"2016","unstructured":"Ponsioen, C.Y., et al., Surrogate endpoints for clinical trials in primary sclerosing cholangitis: Review and results from an International PSC Study Group consensus process. Hepatology, 2016. 63(4): p. 1357-67.","journal-title":"Hepatology"},{"issue":"4","key":"2366_CR7","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1136\/gut.51.4.562","volume":"51","author":"CY Ponsioen","year":"2002","unstructured":"Ponsioen, C.Y., et al., Natural history of primary sclerosing cholangitis and prognostic value of cholangiography in a Dutch population. Gut, 2002. 51(4): p. 562-6.","journal-title":"Gut"},{"issue":"7","key":"2366_CR8","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.cgh.2012.12.032","volume":"11","author":"L Lindstrom","year":"2013","unstructured":"Lindstrom, L., et al., Association between reduced levels of alkaline phosphatase and survival times of patients with primary sclerosing cholangitis. Clin Gastroenterol Hepatol, 2013. 11(7): p. 841-6.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"2366_CR9","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.dld.2010.12.008","volume":"43","author":"PP Stanich","year":"2011","unstructured":"Stanich, P.P., et al., Alkaline phosphatase normalization is associated with better prognosis in primary sclerosing cholangitis. Dig Liver Dis, 2011. 43(4): p. 309-13.","journal-title":"Dig Liver Dis"},{"issue":"6","key":"2366_CR10","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1111\/jgh.13263","volume":"31","author":"JE Eaton","year":"2016","unstructured":"Eaton, J.E., et al., Performance of magnetic resonance elastography in primary sclerosing cholangitis. J Gastroenterol Hepatol, 2016. 31(6): p. 1184-90.","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"2366_CR11","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/hep.26620","volume":"59","author":"A Ruiz","year":"2014","unstructured":"Ruiz, A., et al., Radiologic course of primary sclerosing cholangitis: assessment by three-dimensional magnetic resonance cholangiography and predictive features of progression. Hepatology, 2014. 59(1): p. 242-50.","journal-title":"Hepatology"},{"issue":"2","key":"2366_CR12","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/j.1365-2559.2011.03853.x","volume":"60","author":"B Portmann","year":"2012","unstructured":"Portmann, B. and Y. Zen, Inflammatory disease of the bile ducts-cholangiopathies: liver biopsy challenge and clinicopathological correlation. Histopathology, 2012. 60(2): p. 236-48.","journal-title":"Histopathology"},{"issue":"5","key":"2366_CR13","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1016\/j.jhep.2015.06.008","volume":"63","author":"EM de Vries","year":"2015","unstructured":"de Vries, E.M., et al., Applicability and prognostic value of histologic scoring systems in primary sclerosing cholangitis. J Hepatol, 2015. 63(5): p. 1212-9.","journal-title":"J Hepatol"},{"issue":"12","key":"2366_CR14","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1007\/s10620-006-9720-1","volume":"52","author":"BD Petrovic","year":"2007","unstructured":"Petrovic, B.D., et al., Correlation between findings on MRCP and gadolinium-enhanced MR of the liver and a survival model for primary sclerosing cholangitis. Dig Dis Sci, 2007. 52(12): p. 3499-506.","journal-title":"Dig Dis Sci"},{"key":"2366_CR15","doi-asserted-by":"crossref","unstructured":"Corpechot, C., et al., Baseline values and changes in liver stiffness measured by transient elastography are associated with severity of fibrosis and outcomes of patients with primary sclerosing cholangitis. Gastroenterology, 2014. 146(4): p. 970-9; quiz e15-6.","DOI":"10.1053\/j.gastro.2013.12.030"},{"issue":"4","key":"2366_CR16","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1007\/s00330-015-3913-y","volume":"26","author":"H Hinrichs","year":"2016","unstructured":"Hinrichs, H., et al., Functional gadoxetate disodium-enhanced MRI in patients with primary sclerosing cholangitis (PSC). Eur Radiol, 2016. 26(4): p. 1116-24.","journal-title":"Eur Radiol"},{"issue":"3","key":"2366_CR17","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1177\/0284185112471792","volume":"54","author":"JD Kovac","year":"2013","unstructured":"Kovac, J.D., et al., MR imaging of primary sclerosing cholangitis: additional value of diffusion-weighted imaging and ADC measurement. Acta Radiol, 2013. 54(3): p. 242-8.","journal-title":"Acta Radiol"},{"issue":"6","key":"2366_CR18","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1002\/hep.510290607","volume":"29","author":"WR Kim","year":"1999","unstructured":"Kim, W.R., et al., The relative role of the Child-Pugh classification and the Mayo natural history model in the assessment of survival in patients with primary sclerosing cholangitis. Hepatology, 1999. 29(6): p. 1643-8.","journal-title":"Hepatology"},{"issue":"3","key":"2366_CR19","first-page":"251","volume":"7","author":"RG Olsson","year":"1995","unstructured":"Olsson, R.G. and M.S. Asztely, Prognostic value of cholangiography in primary sclerosing cholangitis. Eur J Gastroenterol Hepatol, 1995. 7(3): p. 251-4.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"2366_CR20","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jhep.2009.01.023","volume":"51","author":"G Rudolph","year":"2009","unstructured":"Rudolph, G., et al., Influence of dominant bile duct stenoses and biliary infections on outcome in primary sclerosing cholangitis. J Hepatol, 2009. 51(1): p. 149-55.","journal-title":"J Hepatol"},{"issue":"2","key":"2366_CR21","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0168-8278(01)00251-3","volume":"36","author":"A Stiehl","year":"2002","unstructured":"Stiehl, A., et al., Development of dominant bile duct stenoses in patients with primary sclerosing cholangitis treated with ursodeoxycholic acid: outcome after endoscopic treatment. J Hepatol, 2002. 36(2): p. 151-6.","journal-title":"J Hepatol"},{"issue":"1","key":"2366_CR22","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1002\/hep.27825","volume":"62","author":"M Vesterhus","year":"2015","unstructured":"Vesterhus, M., et al., Enhanced liver fibrosis score predicts transplant-free survival in primary sclerosing cholangitis. Hepatology, 2015. 62(1): p. 188-97.","journal-title":"Hepatology"},{"issue":"2","key":"2366_CR23","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1148\/radiol.10091953","volume":"256","author":"M Dave","year":"2010","unstructured":"Dave, M., et al., Primary sclerosing cholangitis: meta-analysis of diagnostic performance of MR cholangiopancreatography. Radiology, 2010. 256(2): p. 387-96.","journal-title":"Radiology"},{"issue":"3","key":"2366_CR24","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1002\/jmri.23683","volume":"36","author":"A Frydrychowicz","year":"2012","unstructured":"Frydrychowicz, A., et al., Gadoxetic acid-enhanced T1-weighted MR cholangiography in primary sclerosing cholangitis. J Magn Reson Imaging, 2012. 36(3): p. 632-40.","journal-title":"J Magn Reson Imaging"},{"issue":"1","key":"2366_CR25","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/jmri.24381","volume":"40","author":"KI Ringe","year":"2014","unstructured":"Ringe, K.I., et al., Gadoxetate disodium in patients with primary sclerosing cholangitis: an analysis of hepatobiliary contrast excretion. J Magn Reson Imaging, 2014. 40(1): p. 106-12.","journal-title":"J Magn Reson Imaging"},{"issue":"5","key":"2366_CR26","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1002\/hep.29293","volume":"66","author":"C Schramm","year":"2017","unstructured":"Schramm, C., et al., Recommendations on the use of magnetic resonance imaging in PSC-A position statement from the International PSC Study Group. Hepatology, 2017. 66(5): p. 1675-1688.","journal-title":"Hepatology"},{"issue":"3","key":"2366_CR27","doi-asserted-by":"publisher","first-page":"e0193929","DOI":"10.1371\/journal.pone.0193929","volume":"13","author":"S Keller","year":"2018","unstructured":"Keller, S., et al., Association of gadolinium-enhanced magnetic resonance imaging with hepatic fibrosis and inflammation in primary sclerosing cholangitis. PLoS One, 2018. 13(3): p. e0193929.","journal-title":"PLoS One"},{"issue":"2","key":"2366_CR28","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1007\/s00330-018-5614-9","volume":"29","author":"S Keller","year":"2019","unstructured":"Keller, S., et al., Prospective comparison of diffusion-weighted MRI and dynamic Gd-EOB-DTPA-enhanced MRI for detection and staging of hepatic fibrosis in primary sclerosing cholangitis. Eur Radiol, 2019. 29(2): p. 818-828.","journal-title":"Eur Radiol"},{"key":"2366_CR29","doi-asserted-by":"crossref","unstructured":"Tenca, A., et al., The role of magnetic resonance imaging and endoscopic retrograde cholangiography in the evaluation of disease activity and severity in primary sclerosing cholangitis. Liver Int, 2018.","DOI":"10.1111\/liv.13899"},{"issue":"7","key":"2366_CR30","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/S0025-6196(11)64614-4","volume":"75","author":"WR Kim","year":"2000","unstructured":"Kim, W.R., et al., A revised natural history model for primary sclerosing cholangitis. Mayo Clin Proc, 2000. 75(7): p. 688-94.","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"2366_CR31","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1002\/hep.21563","volume":"45","author":"Patrick S. Kamath","year":"2007","unstructured":"Kamath, P.S., W.R. Kim, and G. Advanced Liver Disease Study, The model for end-stage liver disease (MELD). Hepatology, 2007. 45(3): p. 797-805.","journal-title":"Hepatology"},{"issue":"4","key":"2366_CR32","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1111\/j.1478-3231.2009.02192.x","volume":"30","author":"BK Kim","year":"2010","unstructured":"Kim, B.K., et al., Validation of FIB-4 and comparison with other simple noninvasive indices for predicting liver fibrosis and cirrhosis in hepatitis B virus-infected patients. Liver Int, 2010. 30(4): p. 546-53.","journal-title":"Liver Int"},{"key":"2366_CR33","doi-asserted-by":"crossref","unstructured":"Durand, F. and D. Valla, Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD. J Hepatol, 2005. 42 Suppl(1): p. S100-7.","DOI":"10.1016\/j.jhep.2004.11.015"},{"issue":"3","key":"2366_CR34","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/j.1440-1827.2009.02500.x","volume":"60","author":"Y Nakanuma","year":"2010","unstructured":"Nakanuma, Y., et al., Application of a new histological staging and grading system for primary biliary cirrhosis to liver biopsy specimens: Interobserver agreement. Pathol Int, 2010. 60(3): p. 167-74.","journal-title":"Pathol Int"},{"key":"2366_CR35","unstructured":"Lemoinne, S., et al., Simple Magnetic Resonance Scores Associate With Outcomes of Patients With Primary Sclerosing Cholangitis. Clin Gastroenterol Hepatol, 2019."},{"issue":"1","key":"2366_CR36","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.cld.2015.08.013","volume":"20","author":"C Corpechot","year":"2016","unstructured":"Corpechot, C., Utility of Noninvasive Markers of Fibrosis in Cholestatic Liver Diseases. Clin Liver Dis, 2016. 20(1): p. 143-58.","journal-title":"Clin Liver Dis"}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-019-02366-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00261-019-02366-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-019-02366-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,15]],"date-time":"2020-12-15T00:43:30Z","timestamp":1607993010000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00261-019-02366-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,16]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["2366"],"URL":"https:\/\/doi.org\/10.1007\/s00261-019-02366-9","relation":{},"ISSN":["2366-004X","2366-0058"],"issn-type":[{"value":"2366-004X","type":"print"},{"value":"2366-0058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,16]]},"assertion":[{"value":"16 December 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}